Cargando…
Prostate cancer screening: Continued controversies and novel biomarker advancements
Prostate cancer (PCa) screening remains one of the most controversial topics in clinical and public health. Despite being the second most common cancer in men worldwide, recommendations for screening using prostate-specific antigen (PSA) are unclear. Early detection and the resulting postscreening t...
Autores principales: | Tidd-Johnson, Atiyah, Sebastian, Sneha Annie, Co, Edzel Lorraine, Afaq, Munaza, Kochhar, Hansini, Sheikh, Mona, Mago, Arpit, Poudel, Sujan, Fernandez, John A., Rodriguez, Ivan D., Razdan, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875204/ https://www.ncbi.nlm.nih.gov/pubmed/36714234 http://dx.doi.org/10.1097/CU9.0000000000000145 |
Ejemplares similares
-
Re: Microwave focal therapy of prostate cancer: A non-clinical study and exploratory clinical trial
por: Tan, Wei Phin
Publicado: (2023) -
Penile metastasis in prostate cancer patients: Two case reports, surgical excision technique, and literature review
por: Landen, Lucas, et al.
Publicado: (2023) -
Clinical and prostate multiparametric magnetic resonance imaging findings as predictors of general and clinically significant prostate cancer risk: A retrospective single-center study
por: Massanova, Matteo, et al.
Publicado: (2023) -
Learning curve for magnetic resonance imaging/ultrasound fusion prostate biopsy in detecting prostate cancer using cumulative sum analysis
por: Xu, Linhan, et al.
Publicado: (2023) -
Feasibility of cabazitaxel in octogenarian prostate cancer patients
por: Tralongo, Paolo, et al.
Publicado: (2023)